[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Filters

Search
Categories
1,808
Publishers
1
4
3
1
6
56
5
2
2
10
9
1
5
97
28
14
3
100
7
1
8
107
2
1
1
6
12
2
9
1
11
18
83
15
8
1
4
12
1
5
11
2
43
3
4
2
29
843
5
25
2
47
16
10
6
10
12
5
1
10
17
2
30
4
7
Regions
36
11
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
29
22
22
5
4
79
65
51
51
51
50
51
113
972
Price
Date
Pages
Offers
1
1

Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Publications found: 1,808
Sort by:
Global Cancer Immunotherapy Market Analysis & Forecast to 2023: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors US$ 4,900.00

Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that hav...

January 2020 450 pages
Global Neoantigen Cancer Vaccine Market : Focus on Application, Approach, Type, Line of Therapy, Treatment Strategy, Country Data (15 Countries),and Competitive Landscape – Analysis and Forecast, 2023-2030 US$ 5,000.00

Key Questions Answered in this Report:What are the major market drivers, challenges, and opportunities in the global neoantigen cancer vaccine market?What are the underlying structures resulting in th...

December 2019 255 pages
High-Grade Glioma Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

December 2019 269 pages
Aplastic Anemia Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

December 2019 241 pages
Malignant Mesothelioma Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

December 2019 383 pages
T-Cell Leukemia Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

December 2019 221 pages
Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

December 2019 199 pages
Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H2, 2017' provides an overview of Metastatic Transitional (Urothelial) Tract Cancer clinical trials ...

December 2019 224 pages
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 US$ 4,000.00

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 SUMMARY GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018' provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage. The ...

December 2019 439 pages
Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 US$ 4,000.00

... of Lung Cancer Diagnostic Tests and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage The ...

December 2019 555 pages
Triple-Negative Breast Cancer (TNBC) Global Clinical Trials Review, H2, 2019 US$ 2,500.00

Triple-Negative Breast Cancer (TNBC) Global Clinical Trials Review, H2, 2019 SUMMARY GlobalData's clinical trial report, “Triple-Negative Breast Cancer (TNBC) Global Clinical Trials Review, H2, 2019...

December 2019 731 pages
Fallopian Tube Cancer Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

December 2019 804 pages
Bladder Cancer Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

December 2019 908 pages
Rectal Cancer Global Clinical Trials Review, H2, 2019 US$ 2,500.00

Rectal Cancer Global Clinical Trials Review, H2, 2019 SUMMARY GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2019' provides an overview of Rectal Cancer clinic...

December 2019 689 pages
Angioimmunoblastic T-Cell Lymphoma (AITL) Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2019 US$ 2,500.00

... Global Clinical Trials Review, H2, 2018 SUMMARY GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018' provides an overview of Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy clinical trials ...

December 2019 220 pages
Colorectal Cancer: Epidemiology Forecast to 2028 US$ 3,995.00

Colorectal Cancer: Epidemiology Forecast to 2028 SUMMARY Colorectal cancer (CRC) is a cancer that occurs in the large intestine or large bowel (Centers for Disease Control and Prevention, 2019). Mos...

November 2019 47 pages
HER2-Negative Breast Cancer: Epidemiology Forecast to 2028 US$ 3,995.00

HER2-Negative Breast Cancer: Epidemiology Forecast to 2028 SUMMARY Breast cancer is a malignant tumor that originates in the breast tissue. Most breast cancers are invasive tumors that have grown be...

November 2019 61 pages
Breast Cancer Diagnostic and Drug Technologies: Global Markets US$ 4,400.00

... current report. This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic ...

November 2019 150 pages
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 US$ 2,500.00

... players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging ...

November 2019 113 pages
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 US$ 4,000.00

... may be removed or altered based on the availability and relevance of data in relation to the equipment type. SCOPE Extensive coverage of the Liver Cancer Diagnostic Tests under development The ...

November 2019 132 pages
Global Cancer Vaccine Partnering 2014-2019: Deal trends, players and financials US$ 2,995.00

... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...

November 2019 120 pages
Global Oncology Partnering 2014-2019: Deal trends, players and financials US$ 3,495.00

... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...

November 2019 2400 pages
Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players and financials US$ 2,995.00

... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

November 2019 400 pages
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials US$ 2,995.00

... cancer monoclonal antibody deals by value since 2014 In Cancer Monoclonal Antibody Partnering Terms & Agreements, the available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific oncology ...

November 2019 300 pages
Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026 US$ 2,600.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. “Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026” Report...

October 2019 170 pages
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028 US$ 10,995.00

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028 SUMMARY Ovarian cancer is a rare gynecological disease that spans a broad range of genetic and histological subtypes, for which platinum-ba...

September 2019 162 pages
Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecast to 2025 US$ 4,475.00

... Cobalt-60 based teletherapy Proton Therapy Internal Beam Radiotherapy Brachytherapy Systemic Radiotherapy Market by Product Radiotherapy Devices External beam radiotherapy systems Conventional Linear Accelerators (LINAC) Conventional ...

September 2019 327 pages
Cancer Diagnostics Companies in China US$ 1,800.00

This study focuses on China’s Cancer Diagnostics industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

September 2019 53 pages
Cancer Diagnostics Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Cancer Diagnostics industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

September 2019 103 pages
Cancer Diagnostics Markets in China US$ 4,000.00

China's demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

September 2019 213 pages
Prostate Cancer: Epidemiology Forecast to 2028 US$ 3,995.00

Prostate Cancer: Epidemiology Forecast to 2028 SUMMARY Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about...

August 2019 48 pages
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028 US$ 10,995.00

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028 SUMMARY The prostate cancer market in the 8 major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) is expected...

August 2019 212 pages
Colorectal Cancer - Global Market Outlook (2017-2026) US$ 4,150.00

According to Stratistics MRC, the Global Colorectal Cancer Market is accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion ... primary one being greater prevalence of colorectal cancer. Some of the key players profiled in the Colorectal Cancer market include Abbott Laboratories, Amgen Inc., ...

August 2019 137 pages
Pancreatic Cancer - Global Market Outlook (2017-2026) US$ 4,150.00

According to Stratistics MRC, the Global Pancreatic Cancer market is accounted for $1,904.20 million in 2017 and is expected to reach $4,728.19 ... sector over the globe. Some of the key players in the Pancreatic Cancer market include Novartis Ag, Eli Lily and Company, F. Hoffmann-La Roche AG, Pharmacyte ...

August 2019 183 pages
Prostate Cancer - Global Market Outlook (2017-2026) US$ 4,150.00

According to Stratistics MRC, the Global Prostate Cancer market is growing at a CAGR of 10.3% during the forecast period. Some of the key ... commodities, which is likely to boost county market growth. Some of the key players profiled in the Prostate Cancer Market include Astellas, Inc., AstraZeneca plc, Bristol ...

August 2019 155 pages
Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025 US$ 4,175.00

Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation)], Product [ ...

August 2019 251 pages
Ovarian Cancer: Epidemiology Forecast to 2028 US$ 3,995.00

Ovarian Cancer: Epidemiology Forecast to 2028 SUMMARY Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is def...

July 2019 46 pages
Global Cancer or Tumor Profiling Market Size study, By Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry, other technologies), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer, other cancer), By Applications (Clinical Application, Research Applications) and Regional Forecasts 2019-2026. US$ 3,950.00

... by 2025. Increasing number of breast cancer cases would supplement global Cancer or Tumor profiling market for the forecasted period. However, ... , the Cancer or Tumor Profiling market is segmented into technology, cancer type and application. The technology segment of global Cancer or Tumor Profiling market is ...

July 2019 200 pages
Pancreatic cancer Global Clinical Trials Review, H2, 2019 US$ 2,500.00

Pancreatic cancer Global Clinical Trials Review, H2, 2019 SUMMARY GlobalData's clinical trial report, “Pancreatic cancer Global Clinical Trials Review, H2, 2019' provides an overview of End-Stage Ki...

July 2019 2082 pages
Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunotherapy US$ 2,000.00

REPORT INCLUDES: An overview of Tumor Infiltrating Lymphocytes (TILs) for the treatment of metastatic cancer Discussion of the development of TIL as a ... ATCT in a variety of other solid tumors Comparison between two main technologies of tumor immunotherapy, chimeric antibody receptor engineered T Cell ( ...

July 2019 21 pages
Global Cancer Stem Cell Therapy Market, Price, Dosage & Clinical Trial Insight 2025 US$ 3,000.00

... Global Cord Blood Transplant Market Opportunity Cancer Stem Cell Therapy Clinical Pipeline: 37 Therapies Majority Stem Cells In Preclinical Phase: 18 Therapies Cancer Stem Cell Therapy Clinical Pipeline by Country: More Than 30 In USA Post Therapy Cancer Stem Cell Targeting Drugs Cancer ...

June 2019 170 pages
France Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,750.00

... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... demand for malignancy assays and the rapid market expansion worldwide. France Market Overview Five-year test volume and sales ...

June 2019 585 pages
Italy Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,750.00

... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... demand for malignancy assays and the rapid market expansion worldwide. Italy Market Overview Five-year test volume and sales ...

June 2019 570 pages
Japan Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,750.00

... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... demand for malignancy assays and the rapid market expansion worldwide. Japan Market Overview Five-year test volume and sales ...

June 2019 590 pages
Spain Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,750.00

... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... demand for malignancy assays and the rapid market expansion worldwide. Spain Market Overview Five-year test volume and sales ...

June 2019 565 pages
Germany Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,750.00

... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... demand for malignancy assays and the rapid market expansion worldwide. Germany Market Overview Five-year test volume and sales ...

June 2019 585 pages
UK Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,750.00

... emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets, reviews current and ... and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers ...

June 2019 565 pages
US Cancer Diagnostics Market. 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies US$ 4,850.00

... in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer diagnostics markets, reviews current and ... and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers ...

June 2019 620 pages